1don MSN
New method reveals how mutations drive transthyretin amyloidosis and guides precision drug design
An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...
The Chosun Ilbo on MSN
Global and Korean Pharma Race Alzheimer's Drug Development
U.S. pharmaceutical company Eli Lilly plans to disclose the top-line results of its phase 3 clinical trial for ‘remternutux,’ a new drug candidate being developed as a successor to its Alzheimer’s ...
An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein transthyretin that cause ...
Alzheimer's disease (AD) is a serious neurodegenerative disease largely affecting older adults. Apart from age, it also shows ...
3don MSN
Common blood protein protects patients from lethal 'black fungus' infection, new study finds
Albumin is the most common protein in the blood, a vital molecule produced by the liver that helps maintain fluid balance and ...
4don MSN
Boosting the cell's own cleanup: New class of small molecules accelerate natural protein degradation
Proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback